Thursday, February 14, 2013

• INCYTE CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online (Thu, Feb 14)
• Incyte Reports 2012 Fourth-Quarter and Full-Year Financial Results; Provides 2013 Financial Guidance; Updates Shareholders on Key Clinical ProgramsBusiness Wire (Thu, Feb 14)

Tuesday, February 12, 2013

• Novartis Marrow Drug Fails to Win U.K. Agency Backingat Bloomberg (Tue, Feb 12)

Monday, February 11, 2013

• Update on Lilly's TabalumabZacks (Mon, Feb 11)

Tuesday, February 5, 2013

• Incyte Pharmaceuticals Is Primed For A Runat Seeking Alpha (Tue, Feb 5)

Thursday, January 31, 2013

• Lilly Makes the Best of Bad Newsat Motley Fool (Thu, Jan 31)

Wednesday, January 30, 2013

• Foolish Preview: Pfizer Earningsat Motley Fool (Wed, Jan 30)

Thursday, January 24, 2013

• Incyte to Report Fourth Quarter/Year-End 2012 Financial Results on February 14Business Wire (Thu, Jan 24)

Sunday, January 20, 2013

• Heroic, But Profitable For Investors?at Motley Fool (Sun, Jan 20)

Friday, January 18, 2013

• 4 Promising Growth Stories In Therapeuticsat Seeking Alpha (Fri, Jan 18)

Tuesday, January 15, 2013

• Why This Pharma is Set for a Great 2013at Motley Fool (Tue, Jan 15)

Monday, January 14, 2013

• 4 Stocks Spiking on Unusual Volumeat TheStreet (Mon, Jan 14)

Thursday, January 10, 2013

• Will 2013 Be A Better Year For Zalicus?at Seeking Alpha (Thu, Jan 10)

Tuesday, January 8, 2013

• JPMorgan Healthcare Conference Highlights: Incyteat Motley Fool (Tue, Jan 8)

Monday, January 7, 2013

• Incyte's CEO Presents at 31st Annual J. P. Morgan Healthcare Conference (Transcript)at Seeking Alpha (Mon, Jan 7)

Wednesday, January 2, 2013

• Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate IncreasesMarketwired (Wed, Jan 2)

Thursday, December 27, 2012

• Rheumatoid Arthritis Review – Focus Eli Lilyat Motley Fool (Thu, Dec 27)

Thursday, December 20, 2012

• Top Buys by Directors: DE's $725K Bet on INCYat Forbes (Thu, Dec 20)

Wednesday, December 19, 2012

• Sensata Target Raised and 4 Must-See Stock Analysesat Wall St. Cheat Sheet (Wed, Dec 19)
• Incyte to Present at the 31st Annual J. P. Morgan Healthcare ConferenceBusiness Wire (Wed, Dec 19)
• Will What Happened to Lilly in 2012 Stay in 2012?at Motley Fool (Wed, Dec 19)
• Incyte should outperform in 2013, says JMP Securitiesat theflyonthewall.com (Wed, Dec 19)

Monday, December 17, 2012

• Eli Lilly Scraps a Phase III StudyZacks (Mon, Dec 17)

Sunday, December 16, 2012

• 1 Buyout Bolstering Big Biotechat Motley Fool (Sun, Dec 16)

Saturday, December 15, 2012

• Good, Not Great, Isn't Good Enoughat Motley Fool (Sat, Dec 15)

Add INCY News to My Yahoo!